Related Experiment Videos
[Acute and chronic mechanical circulatory support]
F R Waldenberger1, H R Laube, W Konertz
1Universitáatsklinikum Charité, Klinik für Herzchirurgie, Berlin.
Zeitschrift Fur Kardiologie
|January 1, 1996
Summary
Mechanical circulatory support devices are increasingly used for heart failure. This study shows successful weaning in 10 of 21 patients, demonstrating effective circulatory support for various cardiac conditions.
Area of Science:
- Cardiology
- Biomedical Engineering
- Mechanical Circulatory Support
Background:
- Mechanical circulatory support (MCS) and left ventricular unloading are standard treatments for acute and chronic heart failure.
- Advancements in cardiac assist systems allow for tailored support levels based on clinical needs.
Purpose of the Study:
- To report clinical experience with various MCS devices (Hemopump, centrifugal pumps, Medos, HIAVAD, Novacor) between January 1994 and May 1995.
- To evaluate the efficacy and outcomes of MCS in patients with diverse cardiac failure etiologies.
Main Methods:
- Implantation of MCS devices in 21 patients.
- Indications included post-infarct cardiac failure, postcardiotomy cardiac failure, elective postcardiotomy support, myocarditis-induced cardiac failure, and as a bridge to transplant.
- Devices used: Hemopump, centrifugal pumps, Medos, HIAVAD, and Novacor.
Main Results:
- Ten out of 21 patients survived mechanical support and were successfully weaned.
- Circulatory support was adequate in all cases.
- Discussion of optimal indications, timing, anticoagulation, and infection prevention strategies.
Conclusions:
- Mechanical circulatory support can be effectively utilized in managing severe heart failure.
- Successful weaning is achievable, highlighting the potential of MCS as a therapeutic option.
- Careful patient selection, device management, and prophylactic measures are crucial for favorable outcomes.